BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 32998865)

  • 1. In vitro elimination of autoreactive B cells from rheumatoid arthritis patients by universal chimeric antigen receptor T cells.
    Zhang B; Wang Y; Yuan Y; Sun J; Liu L; Huang D; Hu J; Wang M; Li S; Song W; Chen H; Zhou D; Zhang X
    Ann Rheum Dis; 2021 Feb; 80(2):176-184. PubMed ID: 32998865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selected cyclic citrullinated peptides derived from the sequence of mutated and citrullinated vimentin (MCV) are targeted by different antibodies subclasses in patients with rheumatoid arthritis in Russian patients.
    Derganova O; Martinez-Gamboa L; Egerer K; Bang H; Fredenhagen G; Roggenbuck D; Esaulenko I; Burmester GR; Chernykh T; Feist E
    Clin Exp Rheumatol; 2014; 32(5):622-9. PubMed ID: 25189876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients.
    Snir O; Widhe M; Hermansson M; von Spee C; Lindberg J; Hensen S; Lundberg K; Engström A; Venables PJ; Toes RE; Holmdahl R; Klareskog L; Malmström V
    Arthritis Rheum; 2010 Jan; 62(1):44-52. PubMed ID: 20039432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody responses to de novo identified citrullinated fibrinogen peptides in rheumatoid arthritis and visualization of the corresponding B cells.
    Joshua V; Schobers L; Titcombe PJ; Israelsson L; Rönnelid J; Hansson M; Catrina AI; Pruijn GJ; Malmström V
    Arthritis Res Ther; 2016 Dec; 18(1):284. PubMed ID: 27906052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation and Characterization of Anti-Citrullinated Protein Antibody-Producing B Cell Clones From Rheumatoid Arthritis Patients.
    Germar K; Fehres CM; Scherer HU; van Uden N; Pollastro S; Yeremenko N; Hansson M; Kerkman PF; van der Voort EIH; Reed E; Maassen H; Kwakkenbos MJ; Bakker AQ; Klareskog L; Malmström V; de Vries N; Toes REM; Lundberg K; Spits H; Baeten DL
    Arthritis Rheumatol; 2019 Mar; 71(3):340-350. PubMed ID: 30277007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of anti-citrullinated protein/peptide antibodies in rheumatoid arthritis using peptides mimicking endogenously citrullinated fibrinogen antigens.
    Fernandes-Cerqueira C; Ossipova E; Gunasekera S; Hansson M; Mathsson L; Catrina AI; Sommarin Y; Klareskog L; Lundberg K; Rönnelid J; Göransson U; Jakobsson PJ
    Arthritis Res Ther; 2015 Jun; 17(1):155. PubMed ID: 26059223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential Prodrug Strategy To Target and Eliminate ACPA-Selective Autoreactive B Cells.
    Lelieveldt LPWM; Kristyanto H; Pruijn GJM; Scherer HU; Toes REM; Bonger KM
    Mol Pharm; 2018 Dec; 15(12):5565-5573. PubMed ID: 30289723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell autoreactivity to citrullinated autoantigenic peptides in rheumatoid arthritis patients carrying HLA-DRB1 shared epitope alleles.
    Law SC; Street S; Yu CH; Capini C; Ramnoruth S; Nel HJ; van Gorp E; Hyde C; Lau K; Pahau H; Purcell AW; Thomas R
    Arthritis Res Ther; 2012 May; 14(3):R118. PubMed ID: 22594821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The autoantibody response to cyclic citrullinated collagen type II peptides in rheumatoid arthritis.
    Liang B; Ge C; Lönnblom E; Lin X; Feng H; Xiao L; Bai J; Ayoglu B; Nilsson P; Nandakumar KS; Zhao M; Holmdahl R
    Rheumatology (Oxford); 2019 Sep; 58(9):1623-1633. PubMed ID: 30892636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis.
    Schwenzer A; Jiang X; Mikuls TR; Payne JB; Sayles HR; Quirke AM; Kessler BM; Fischer R; Venables PJ; Lundberg K; Midwood KS
    Ann Rheum Dis; 2016 Oct; 75(10):1876-83. PubMed ID: 26659718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.
    Snir O; Widhe M; von Spee C; Lindberg J; Padyukov L; Lundberg K; Engström A; Venables PJ; Lundeberg J; Holmdahl R; Klareskog L; Malmström V
    Ann Rheum Dis; 2009 May; 68(5):736-43. PubMed ID: 18635594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of citrullinated vimentin peptides as T cell epitopes in HLA-DR4-positive patients with rheumatoid arthritis.
    Feitsma AL; van der Voort EI; Franken KL; el Bannoudi H; Elferink BG; Drijfhout JW; Huizinga TW; de Vries RR; Toes RE; Ioan-Facsinay A
    Arthritis Rheum; 2010 Jan; 62(1):117-25. PubMed ID: 20039411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are there autoantibodies reacting against citrullinated peptides derived from type I and type II collagens in patients with rheumatoid arthritis?
    Koivula MK; Aman S; Karjalainen A; Hakala M; Risteli J
    Ann Rheum Dis; 2005 Oct; 64(10):1443-50. PubMed ID: 16162901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of anti-citrullinated protein or peptide antibodies with left ventricular structure and function in rheumatoid arthritis.
    Geraldino-Pardilla L; Russo C; Sokolove J; Robinson WH; Zartoshti A; Van Eyk J; Fert-Bober J; Lima J; Giles JT; Bathon JM
    Rheumatology (Oxford); 2017 Apr; 56(4):534-540. PubMed ID: 27994093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B cell depletion with rituximab in patients with rheumatoid arthritis: Multiplex bead array reveals the kinetics of IgG and IgA antibodies to citrullinated antigens.
    Cambridge G; Leandro MJ; Lahey LJ; Fairhead T; Robinson WH; Sokolove J
    J Autoimmun; 2016 Jun; 70():22-30. PubMed ID: 27055777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic Citrulline-Multispecific B Cell Receptor Clades in Rheumatoid Arthritis.
    Titcombe PJ; Wigerblad G; Sippl N; Zhang N; Shmagel AK; Sahlström P; Zhang Y; Barsness LO; Ghodke-Puranik Y; Baharpoor A; Hansson M; Israelsson L; Skriner K; Niewold TB; Klareskog L; Svensson CI; Amara K; Malmström V; Mueller DL
    Arthritis Rheumatol; 2018 Dec; 70(12):1933-1945. PubMed ID: 29927106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulation of RA Patients' PBMC with a Multiepitope Peptide Derived from Citrullinated Autoantigens.
    Gertel S; Karmon G; Vainer S; Shovman O; Cornillet M; Serre G; Shoenfeld Y; Amital H
    Mediators Inflamm; 2017; 2017():3916519. PubMed ID: 28751821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-citrullinated peptides as autoantigens in rheumatoid arthritis-relevance to treatment.
    Sakkas LI; Bogdanos DP; Katsiari C; Platsoucas CD
    Autoimmun Rev; 2014 Nov; 13(11):1114-20. PubMed ID: 25182207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citrullinated Aggrecan Epitopes as Targets of Autoreactive CD4+ T Cells in Patients With Rheumatoid Arthritis.
    Rims C; Uchtenhagen H; Kaplan MJ; Carmona-Rivera C; Carlucci P; Mikecz K; Markovics A; Carlin J; Buckner JH; James EA
    Arthritis Rheumatol; 2019 Apr; 71(4):518-528. PubMed ID: 30390384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shared recognition of citrullinated tenascin-C peptides by T and B cells in rheumatoid arthritis.
    Song J; Schwenzer A; Wong A; Turcinov S; Rims C; Martinez LR; Arribas-Layton D; Gerstner C; Muir VS; Midwood KS; Malmström V; James EA; Buckner JH
    JCI Insight; 2021 Mar; 6(5):. PubMed ID: 33507879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.